advancing innovation to save lives

GHTC welcomes House passage of the Global Health Innovation Act

GHTC welcomes passage by the US House of Representatives of the Global Health Innovation Act (H.R. 1660), a bipartisan bill that will strengthen efforts by the US Agency for International Development to develop lifesaving global health technologies.
Learn More

The first step

GHTC released a new two-minute video taking viewers on a journey to discover how sustained investments in global health R&D can unlock health and opportunity for people around the world.
View

Member spotlight: Sabin Vaccine Institute

The Sabin Vaccine Institute makes vaccines more accessible, enables innovation and expands immunization across the globe. As a non-profit with more than two decades of experience, Sabin embodies the legacy of its namesake, Dr. Albert B. Sabin, inventor of the oral polio vaccine and lifelong crusader against poverty and preventable disease. Sabin is committed to extending the full benefits of immunization to all people, regardless of who they are or where they live. Sabin has recently welcomed a major grant to spur innovation toward a universal influenza vaccine.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more
PATH/Patrick McKern
Science Speaks explores R&D financing challenges identified in GHTC briefing paper

Science Speaks highlights findings from the second volume in GHTC's paper series on financing and coordination of health R&D. The article notes the challenges nonprofit product developers face as R&D funding declines, as well as the need to identify innovative new sources of funding to support this work.

View
Paper examines R&D funding for diseases of poverty

GHTC today released a paper that provides unique insight into the funding landscape for global health R&D. The paper examines key financing challenges and opportunities facing organizations that advance the development of new vaccines, drugs, diagnostics, microbicides, and other health products for low- and middle-income countries.

Learn More
View All News & Events

Member Event

PATH/Gabe Bienczycki
5th Global Forum on TB Vaccines
Stop TB Partnership, Aeras, TBVI, THSTi...
Learn More

Community Event

PATH/Aaron Joel Santos
Research!America 2018 Advocacy Awards Dinner
Research!America
Learn More
View All Events
PATH/Gena Morgan
Research Roundup: Two malaria drugs power to limit transmission and the latest on chikungunya and cholera vaccines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Eric Becker
Research Roundup: Understanding the severity of antimicrobial resistance and a request to review a sleeping sickness medicine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide